Application of Lipid-Based Nanocarriers for Antitubercular Drug Delivery: A Review

Application of Lipid-Based Nanocarriers for Antitubercular Drug Delivery: A Review

The antimicrobial drugs currently used for the management of tuberculosis (TB) exhibit poor bioavailability that necessitates prolonged treatment regimens and high dosing frequency to achieve optimal therapeutic outcomes. In addition, these agents cause severe adverse effects, as well as having detr...

Full description

Bibliographic Details
Main Authors: Aristote B. Buya, Bwalya A. Witika, Alain M. Bapolisi, Chiluba Mwila, Grady K. Mukubwa, Patrick B. Memvanga, Pedzisai A. Makoni, Christian I. Nkanga
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Pharmaceutics
Subjects:
tuberculosis
antimicrobial resistance
lipid-based nanocarriers
drug delivery
nanomedicines
Online Access:https://www.mdpi.com/1999-4923/13/12/2041

Internet

https://www.mdpi.com/1999-4923/13/12/2041

Similar Items